Olivier Meyer

Summary

Country: France

Publications

  1. ncbi 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block
    Christine Fritsch
    UPR 9021 Centre National de la Recherche Scientifique, Institut de Biologie Moleculaire et Cellulaire, Strasbourg, France
    Arthritis Res Ther 8:R4. 2006
  2. ncbi [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]
    Olivier Meyer
    Service de Rhumatologie, Hopital Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18
    Ann Med Interne (Paris) 153:520-9. 2002
  3. ncbi Parvovirus B19 and autoimmune diseases
    Olivier Meyer
    Rheumatology Department, Hopital Bichat, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 70:6-11. 2003
  4. ncbi [Hormonal life in systemic lupus and other connective tissue diseases]
    O Meyer
    Service de Rhumatologie, Hopital Bichat Claude Bernard, 46, rue Henri Huchard, 75018 Paris, France
    Gynecol Obstet Fertil 31:746-56. 2003
  5. ncbi Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
    O Meyer
    Service de Rhumatologie, CHU Bichat, AP HP, Paris, France
    Ann Rheum Dis 62:120-6. 2003
  6. ncbi Neonatal cutaneous lupus and congenital heart block: it's not all antibodies
    Olivier Meyer
    Rheumatology Department, Bichat Teaching Hospital, Denis-Diderot University, 75018, Paris, France
    Lancet 362:1596-7. 2003
  7. ncbi [CREST syndrome]
    Olivier Meyer
    Service de Rhumatologie, Hopital Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18
    Ann Med Interne (Paris) 153:183-8. 2002
  8. ncbi Evaluating inflammatory joint disease: how and when can autoantibodies help?
    Olivier Meyer
    Rheumatology Department, Bichat Teaching Hospital, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 70:433-47. 2003
  9. ncbi Atherosclerosis and connective tissue diseases
    O Meyer
    Rheumatology Department, Hopital Bichat, Paris, France
    Joint Bone Spine 68:564-75. 2001
  10. ncbi [Safety and efficacy of vaccination in patients with auto-immune diseases]
    Olivier Meyer
    Service de Rhumatologie, , 75018 Paris
    Rev Prat 54:1631-4. 2004

Collaborators

Detail Information

Publications79

  1. ncbi 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block
    Christine Fritsch
    UPR 9021 Centre National de la Recherche Scientifique, Institut de Biologie Moleculaire et Cellulaire, Strasbourg, France
    Arthritis Res Ther 8:R4. 2006
    ..IgG antibodies to Ro52 peptides 1-13, 107-122, 277-292 and 365-382 may therefore represent important biomarkers to predict a complication in pregnant lupus women with Ro52 antibodies...
  2. ncbi [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]
    Olivier Meyer
    Service de Rhumatologie, Hopital Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18
    Ann Med Interne (Paris) 153:520-9. 2002
    ..Other factors must be taken into account to explain discordant twins (with and without CCHB). More recently anti-Ro/SSA antibodies were associated with QT interval prolongation in newborns without CCHB...
  3. ncbi Parvovirus B19 and autoimmune diseases
    Olivier Meyer
    Rheumatology Department, Hopital Bichat, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 70:6-11. 2003
    ..Here again, the number of clinical cases is small...
  4. ncbi [Hormonal life in systemic lupus and other connective tissue diseases]
    O Meyer
    Service de Rhumatologie, Hopital Bichat Claude Bernard, 46, rue Henri Huchard, 75018 Paris, France
    Gynecol Obstet Fertil 31:746-56. 2003
    ..Among other connective tissue diseases, polymyositis has a very severe obstetrical prognosis for both mother and foetus. Among primary vasculitis, polyarteritis nodosa, as found during pregnancy, can herald a very bad prognosis...
  5. ncbi Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
    O Meyer
    Service de Rhumatologie, CHU Bichat, AP HP, Paris, France
    Ann Rheum Dis 62:120-6. 2003
    ..To study the value of antibodies to citrullinated proteins/peptides for predicting joint outcomes in patients with recent onset rheumatoid arthritis (RA)...
  6. ncbi Neonatal cutaneous lupus and congenital heart block: it's not all antibodies
    Olivier Meyer
    Rheumatology Department, Bichat Teaching Hospital, Denis-Diderot University, 75018, Paris, France
    Lancet 362:1596-7. 2003
  7. ncbi [CREST syndrome]
    Olivier Meyer
    Service de Rhumatologie, Hopital Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18
    Ann Med Interne (Paris) 153:183-8. 2002
    ..Pulmonary hypertension is a very late event and the prognosis is very severe (mortality rate of 50% after 2 years)...
  8. ncbi Evaluating inflammatory joint disease: how and when can autoantibodies help?
    Olivier Meyer
    Rheumatology Department, Bichat Teaching Hospital, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 70:433-47. 2003
    ..In microscopic polyangiitis the ANCAs are peripheral and correspond by ELISA to antimyeloperoxidase antibodies. Tests for other antibodies are less often needed to evaluate inflammatory joint disease...
  9. ncbi Atherosclerosis and connective tissue diseases
    O Meyer
    Rheumatology Department, Hopital Bichat, Paris, France
    Joint Bone Spine 68:564-75. 2001
    ..Early risk factor intervention and effective control of inflammation should be incorporated into the management of connective tissue disease with the goal of protecting patients against atherosclerosis...
  10. ncbi [Safety and efficacy of vaccination in patients with auto-immune diseases]
    Olivier Meyer
    Service de Rhumatologie, , 75018 Paris
    Rev Prat 54:1631-4. 2004
  11. ncbi [Role of anti-TNF therapy in rheumatoid arthritis]
    O Meyer
    Service de Rhumatologie, Hopital Bichat, Paris
    Presse Med 29:463-8. 2000
    ..Is this simply a powerful antiinflammatory treatment or a real curative treatment? A precise examination of radiographic scores will be required to provide the answer to this question...
  12. ncbi Making pregnancy safer for patients with lupus
    Olivier Meyer
    Rheumatology Department, Hopital Bichat, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 71:178-82. 2004
    ..Even with these precautions, however, preterm birth remains common...
  13. ncbi Association of metalloproteinase gene polymorphisms with systemic sclerosis in the European Caucasian population
    Julien Wipff
    Universite Paris Descartes, AP HP, Hopital Cochin, France
    J Rheumatol 37:599-602. 2010
    ..Our aim was to determine whether polymorphisms of the MMP2, MMP9, and MMP14 genes confer susceptibility to SSc in a large population...
  14. ncbi Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients
    Jerome Avouac
    Rheumatology A Department, Paris Descartes University, Cochin Hospital, Paris, France
    J Rheumatol 37:608-14. 2010
    ..To assess the prevalence and potential associations with the systemic sclerosis (SSc) phenotype of additional autoimmune diseases (AID)...
  15. ncbi Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity
    Philippe Dieude
    Service de Rhumatologie, Hopital Bichat Claude Bernard, APHP, Université Diderot Paris 7, Paris, France
    J Rheumatol 37:987-92. 2010
    ..Our aim was to investigate whether IRF5 haplotypes confer susceptibility to SSc, and to perform genotype haplotype-phenotype correlation analyses...
  16. ncbi Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis
    Karen Dawidowicz
    Universite Paris Diderot, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    Clin Exp Rheumatol 29:839-42. 2011
    ..BANK1 and BLK B-cell genetic markers have been reproducibly and convincingly found to contribute to susceptibility to systemic sclerosis (SSc)...
  17. ncbi Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis
    Alexandra Bruns
    Rheumatology Department, Bichat Teaching Hospital, AP HP, CHU Bichat, 46 rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 76:248-53. 2009
    ....
  18. ncbi Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians
    Julien Wipff
    Paris Descartes Université, Rhumatologie A, Hopital Cochin, AP HP, Paris, France
    J Rheumatol 36:337-40. 2009
    ..To determine whether angiotensin-converting enzyme (ACE) polymorphisms including I/D and 2 single-nucleotide polymorphisms (SNP) affect susceptibility to systemic sclerosis (SSc) in a large French Caucasian population...
  19. ncbi High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis
    Fleur Aubart
    Service de Rhumatologie, Hopital Bichat Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France
    J Rheumatol 38:979-82. 2011
    ..To investigate whether levels of anti-cyclic citrullinated peptide antibodies (anti-CCP2) in patients with rheumatoid arthritis (RA) are associated with the co-occurrence of lung diseases...
  20. ncbi Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in European Caucasian population
    Baptiste Coustet
    Inserm U1016, Universite Paris Descartes, Hopital Cochin, Paris, France
    Clin Exp Rheumatol 29:S6-9. 2011
    ..Systemic sclerosis (SSc) belongs to connective tissue disorders and recent data have highlighted strong associations with some autoimmunity genes shared with other autoimmune diseases...
  21. ncbi Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences
    Bruno Fautrel
    Department of Rheumatology, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Arthritis Rheum 61:425-34. 2009
    ..To survey rheumatologists' preferences for the choice of a second-line disease-modifying antirheumatic drug (DMARD) after inadequate response with methotrexate (MTX) therapy in rheumatoid arthritis (RA)...
  22. ncbi Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients
    Michel De Bandt
    Centre hospitalier d Aulnay sous Bois, Service de Rhumatologie, Boulevard Ballanger, Aulnay sous Bois F 93600, France
    Arthritis Res Ther 11:R157. 2009
    ....
  23. ncbi Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts
    Baptiste Coustet
    Universite Paris Descartes, Rhumatologie A, Hopital Cochin, APHP, Paris, France
    J Rheumatol 38:1033-8. 2011
    ..To determine whether novel risk loci associated with systemic lupus erythematosus or multiple sclerosis may confer susceptibility to SSc, we tested single-nucleotide polymorphisms (SNP) from ITGAM, ITGAX, and CD58 for associations...
  24. ncbi C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis
    Baptiste Coustet
    Inserm U1016, Universite Paris Descartes, Paris, France
    Arthritis Rheum 63:2091-6. 2011
    ....
  25. ncbi Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy
    Olivier Meyer
    Department of Rheumatology, AP HP, Bichat Paris 7 University Hospital, CHU Bichat, 46 rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 74:73-8. 2007
    ..The objective was to develop a clinical practice format for choosing a second-line disease-modifying anti-rheumatic drug (DMARD) after a 6-month course of a first-line DMARD in patients with early RA...
  26. ncbi Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study
    Olivier Meyer
    Universite Paris 7 Denis Diderot, UFR de Medecine, APHP Hôpital Bichat, Service de Rhumatologie, Paris, France
    J Rheumatol 37:125-30. 2010
    ..To determine the prevalence of anti-RNA polymerase III autoantibodies in French patients with systemic sclerosis (SSc) and to identify the associated clinical manifestations...
  27. ncbi Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study
    Natacha Courvoisier
    Service de Rhumatologie, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, Paris, 75012, France
    Arthritis Res Ther 10:R106. 2008
    ..The objectives of this study were to determine the predictive factors of long-term radiographic outcome of rheumatoid arthritis (RA) and to describe the relationship between joint damage and disability over the course of the disease...
  28. ncbi Rituximab therapy in rheumatoid arthritis in daily practice
    Noémie Assous
    Department of Rheumatology A and Rheumatology B, Paris Descartes University, Medical Faculty, Cochin Hospital, AP HP, Paris, France
    J Rheumatol 35:31-4. 2008
    ..Our aim was to assess in routine care the effects of rituximab in patients with RA who had experienced an inadequate response to anti-tumor necrosis factor-alpha (TNF-alpha) agents or had a contraindication to these drugs...
  29. ncbi Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients
    Céline Grosjean
    Department of Rheumatology and Department of Immunology, Bichat Teaching Hospital, Paris, France
    J Rheumatol 37:639-43. 2010
    ..To determine the prevalence of the most often tested autoantibodies in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome...
  30. ncbi Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments
    Natacha Thelier
    Department of Rheumatology A, Paris Descartes University, Paris, France
    J Rheumatol 35:1622-8. 2008
    ..To analyze the pattern of osteoarticular lesions in patients with sarcoidosis hospitalized in 4 rheumatology departments...
  31. ncbi Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
    Pascale Nicaise Roland
    Immunology and Haematology Department, Bichat Claude Bernard Teaching Hospital, AP HP, Paris Cedex 18, France
    Arthritis Res Ther 10:R142. 2008
    ..The aims of this study were to evaluate the usefulness of anti-MCV for diagnosing RA in anti-CCP-negative patients and to monitor anti-MCV titres during infliximab therapy for RA...
  32. ncbi Ankylosing spondylitis and systemic sclerosis: a rare combination
    Dieu Donné Ouédraogo
    Service de Rhumatologie, CHU Bichat Claude Bernard, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
    Joint Bone Spine 76:290-2. 2009
    ..This case-report confirms that two inflammatory joint diseases may co-exist, particularly in patients carrying one or two susceptibility alleles to both diseases...
  33. ncbi Predominant cervical involvement in patients with psoriatic arthritis: report of two cases
    Dieu Donné Ouédraogo
    Rheumatology Department, Bichat Teaching Hospital, Paris Cedex 18, France
    Joint Bone Spine 74:175-8. 2007
    ..TNFalpha antagonist therapy (infliximab followed by etanercept) in one patient and phenylbutazone therapy in the other improved the symptoms and led to shrinkage of the pannus...
  34. ncbi Anti-TNF-alpha-induced systemic lupus syndrome
    M Debandt
    Rheumatology Department, Georges Pompidou Teaching Hospital, 20 rue Leblanc, 75015 Paris, France
    Clin Rheumatol 22:56-61. 2003
    ..We report a new case of infliximab-induced lupus syndrome and two new cases of etanercept-induced lupus syndrome in three patients with RA, all of whom had previous isolated positive ANA...
  35. ncbi [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives]
    Olivier Meyer
    Service de Rhumatologie, Hopital Bichat, 46 rue Henri Huchard 75018 Paris
    Bull Acad Natl Med 187:935-54; discussion 954-5. 2003
    ..Cytokines with anti-inflammatory effect (IL4, IL10, IL13...) can also be used for treatment of RA in association with anti-TNF alpha or anti-IL1 beta...
  36. ncbi IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
    Mathieu C Tamby
    Paris Descartes University, Faculty of Medicine, UPRES EA 4058, Paris, France
    Biologics 2:583-91. 2008
    ..These two bands were further identified as DNA topoisomerase 1. Our results indicate that IgG from patients with diffuse systemic sclerosis bind DNA topoisomerase 1 in normal human fibroblasts extracts...
  37. ncbi Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis
    Olivier Meyer
    Rheumatology Unit, Assistance Publique Hopitaux de Paris, Bichat University Hospital, 75018 Paris, France
    Arthritis Res Ther 8:R40. 2006
    ..In conclusion, serially determined anti-CCP2 antibodies during the first three years of follow-up performs better than baseline determination for predicting radiographic progression in patients with early RA...
  38. ncbi Rheumatoid nodulosis. Two cases with destructive polyarthritis after 20 years
    Fabienne Roux
    Rheumatology Department, Bichat Teaching Hospital, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 73:208-11. 2006
    ..In conclusion, these two cases establish that rheumatoid nodulosis can occur as a presentation of rheumatoid arthritis with a potential for severe joint damage after many years...
  39. ncbi Lumboradiculopathy due to epidural varices: two case reports and a review of the literature
    Stephane Genevay
    Department of Rheumatology, Bichat Hospital, Paris, France elisabeth
    Joint Bone Spine 69:214-7. 2002
    ..Our 2 cases corresponded to type 2. The diagnosis can established by MRI at the pre-operative stage. The images vary according to the anatomical type and the age of the lesions. Treatment is by surgery...
  40. ncbi High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis
    Y Allanore
    Rene Descartes University, Cochin Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 58:284-91. 2008
    ..To evaluate predictors of pulmonary arterial hypertension (PAH) in a prospective cohort of patients with systemic sclerosis (SSc)...
  41. ncbi Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease
    B Fautrel
    Department of Rheumatology, Pitie Salpetriere Hospital, Paris, France
    J Rheumatol 28:322-9. 2001
    ..To determine the usefulness of serum ferritin and glycosylated ferritin (GF) levels in diagnosing adult onset Still's disease (AOSD)...
  42. ncbi [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]
    C Georges
    Service de Medecine Interne, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75475 Paris 10, France
    Rev Med Interne 25:16-21. 2004
    ....
  43. ncbi Effects of methotrexate on the oxidative metabolism of cultured rabbit articular chondrocytes
    G Hayem
    Service de Rhumatologie, CHU Bichat Claude Bernard and INSERM U13, Paris, France
    J Rheumatol 27:1117-20. 2000
    ..The mechanism of action of methotrexate (MTX) in inflammatory joint disease is still unclear. We examined the possible interactions of MTX with the oxidative metabolism of rabbit articular chondrocytes...
  44. ncbi Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study
    L Gossec
    , Cochin Hospital, Department of Rheumatology B, Paris, France
    Ann Rheum Dis 63:675-80. 2004
    ..CONCLUSIONS: Baseline prognostic factors for remission in early rheumatoid arthritis were mainly clinical markers of disease activity and radiological scores...
  45. ncbi Spontaneous spinal epidural hematoma with spinal cord compression complicating plasma cell myeloma. A case report
    G Hayem
    Service de Rhumatologie, CHU Bichat Claude Bernard, Paris, France
    Spine (Phila Pa 1976) 23:2432-5. 1998
    ..A case is reported in which a patient had acute paraplegia with sensory loss caused by a spontaneous epidural hematoma that was ascribed to bleeding of pre-existing myeloma lesions of the thoracic vertebrae...
  46. ncbi Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
    C Georges
    AP HP, Internal Medicine, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France
    Clin Rheumatol 24:3-10. 2005
    ..In addition, we suggest the use of a new outcome measure, the SSc HAQ score, to assess this systemic disease more accurately...
  47. ncbi Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome
    M Hurtado-Nedelec
    Immunology, Auto immunity and Hypersensibility Unit, AP HP Bichat Claude Bernard Hospital, Paris, France
    Rheumatology (Oxford) 47:1160-7. 2008
    ..We examined innate and adaptive immune responses in SAPHO syndrome, as compared with PsA and RA. We also studied the effect of etanercept on immunological parameters...
  48. ncbi Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients
    Julien Wipff
    Department of Rheumatology A, Paris Descartes University, Medical Faculty, Cochin Hospital, AP HP, Paris, France
    J Rheumatol 35:643-9. 2008
    ..Significant associations have been found with the fibrillin-1 gene (FBN1) in Choctaw and Japanese populations. We investigated FBN1 polymorphisms in cohorts of European Caucasian patients...
  49. ncbi Prognostic markers for systemic sclerosis
    Olivier Meyer
    Assistance Publique Hopitaux de Paris, Hopital Bichat, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 73:490-4. 2006
    ..Other serum markers for organ involvement are under study, although their predictive performance remains to be evaluated...
  50. ncbi Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome
    G Hayem
    Hĵpital Bichat, Paris, France
    Lupus 10:346-51. 2001
    ..224; P = 0.026). AntiOxLDL elevation was found in 17% of SLE patients and was significantly associated with II APLS and venous thrombosis. We found no evidence suggesting that antiOxLDL may be associated with atherosclerosis...
  51. ncbi JC virus leukoencephalopathy complicating Wegener's granulomatosis
    Christian Pagnoux
    Travail du Service de Rhumatologie, groupe hospitalier Bichat-Claude-Bernard, 46, rue Henri-Huchard, 75877 Paris Cedex 18, France
    Joint Bone Spine 70:376-9. 2003
    ..No specific or effective treatments are available. Immunosuppressant drugs should be discontinued if possible...
  52. ncbi [Immunogenetic bases of systemic lupus erythematosus in humans]
    M Michel
    Unité Inserm U25, Faculte de Medecine Necker, Paris, France
    Rev Med Interne 19:726-30. 1998
    ..To achieve this objective, the recruitment of a large number of genetic traits of multiplex families presenting with SLE is therefore essential. More than 125 multiplex families have been collected to date in France...
  53. ncbi An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis
    S Genevay
    Rheumatology Department, Bichat-Claude Bernard Teaching Hospital, 46 rue Henri Huchard, 75018 Paris, France
    Ann Rheum Dis 61:734-6. 2002
    ..Antifilaggrin antibodies should be included in the initial investigation of patients with RA and, when positive, should alert to a high risk of poor outcomes...
  54. ncbi Interferons and autoimmune disorders
    Olivier Meyer
    Rheumatology Department, Bichat Teaching Hospital, 75018 Paris, France
    Joint Bone Spine 76:464-73. 2009
    ..Immunomodulation strategies designed to decrease interferon overactivity are being evaluated in patients with systemic lupus erythematosus...
  55. ncbi NADPH oxidase priming and p47phox phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis and spondylarthropathy
    Jamel El Benna
    INSERM U479 and Rheumatology Department, C H U Xavier Bichat, 16 rue Henri Huchard, 75018 Paris, France
    Inflammation 26:273-8. 2002
    ..This could be the result of the presence of high levels of priming agents such as TNFalpha and IL-8 but not GM-CSF...
  56. ncbi Anti-CRP antibodies in systemic lupus erythematosus
    Olivier Meyer
    Service de Rhumatologie, CHU Bichat, AP HP, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 77:384-9. 2010
    ..CRP/anti-CRP immune complexes developed in the arterial wall may promote growth of the atheroma plaque...
  57. ncbi Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey
    P Duchet-Niedziolka
    Universite Paris Descartes, Faculté de Médecine AP HP, Groupe Hospitalier Cochin Saint Vincent De Paul, Pôle de médecine, CIC de Vaccinologie Cochin Pasteur INSERM, CIC BT505, Paris, France
    Vaccine 27:1523-9. 2009
    ..The objective of this study was to obtain professional agreement on vaccine practices in these patients...
  58. ncbi Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
    ..This study was undertaken to describe the main characteristics of and long-term outcomes in patients with well-characterized PAN diagnoses...
  59. ncbi Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population
    J Wipff
    Rheumatology A Department, Cochin Hospital, Paris, France
    Ann Rheum Dis 65:1230-2. 2006
    ..38). The PTPN22*620W allele was also not associated with autoantibody patterns. Thus, the PTPN22*R620W polymorphism cannot be regarded as a genetic susceptibility factor for SSc in the French Caucasian population...
  60. ncbi Oculomotor palsy in six patients with systemic lupus erythematosus. A possible role of antiphospholipid syndrome
    S Genevay
    Rheumatology Department, CHU Bichat-Claude Bernard, Paris, France
    Lupus 11:313-6. 2002
    ..In patients with focal NPSLE, a possible cause of OMP is microthrombosis associated with presence of antiphospholipid antibodies...
  61. ncbi Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    N Engl J Med 359:2790-803. 2008
    ..However, azathioprine and methotrexate have not been compared with regard to safety and efficacy...
  62. ncbi BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4
    P Dieude
    Universite Paris 7 Denis Diderot, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    Arthritis Rheum 60:3447-54. 2009
    ....
  63. ncbi STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
    P Dieude
    Université Paris 7 and Service de Rhumatologie, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:2472-9. 2009
    ..The aim of this study was to determine whether the STAT4 rs7574865 single-nucleotide polymorphism is associated with SSc, and whether it interacts with IRF5...
  64. ncbi Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study
    M De Bandt
    Rheumatology Unit, Bichat Teaching Hospital, Paris, France
    J Rheumatol 26:91-6. 1999
    ..To investigate whether serial anticardiolipin determination contributes to the clinical management of patients with systemic lupus erythematosus (SLE) with no previous sign of the antiphospholipid syndrome (APS)...
  65. ncbi [Anticardiolipin antibody in peripheral arterial diseases]
    O Meyer
    Clinique de Rhumatologie, , , Paris
    Arch Mal Coeur Vaiss 84:1645-51. 1991
    ..Immuno-suppressor therapy is not very effective and long-term anticoagulant and/or platelet antiaggregant therapy is usually required...
  66. ncbi The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis
    P Dieude
    Universite Paris 7, Paris, France
    Arthritis Rheum 58:2183-8. 2008
    ..We then conducted a meta-analysis of the most recent studies of SSc in order to verify the association or lack of association between the PTPN22 1858C>T variant and SSc...
  67. ncbi Monoarthritis secondary to joint metastasis. Two case reports and literature review
    Mohamed Younes
    Department of Rheumatology, Bichat-Claude Bernard Teaching Hospital, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 69:495-8. 2002
    ..Joint metastasis carries a poor prognosis with a mean survival of less than 5 months...
  68. ncbi Hip involvement in patients with familial Mediterranean fever. A review of ten cases
    Mohamed Younes
    Rheumatology Department (Professor O. Meyer, Bichat Teaching Hospital, 46, rue Henri-Huchard, 75018 Paris, France
    Joint Bone Spine 69:560-5. 2002
    ..The association of FMF and AS (usually without the HLA-B27 antigen) has been well documented, although the pathogenic mechanisms that link these two conditions remain unknown...
  69. ncbi Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population
    P Dieude
    Universite Paris, Hopital Bichat Claude Bernard, APHP, France
    Ann Rheum Dis 69:1958-64. 2010
    ..TNFAIP3 encodes the ubiquitin-modifying enzyme, a key regulator of inflammatory signalling pathways. Convincing associations between TNFAIP3 variants and autoimmune diseases have been reported...
  70. ncbi Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population
    J Wipff
    Universite Paris Descartes, INSERM U781, Hopital Necker, and Hôpital Cochin, Paris, France
    Arthritis Rheum 62:3093-100. 2010
    ..We undertook this study to determine whether KCNA5 polymorphisms confer susceptibility to SSc and its vascular phenotype, including PAH...
  71. ncbi [Sclerosing cholangitis as a complication of Langerhans'cell histiocytosis]
    C Pagnoux
    Service de Rhumatologie, groupe hospitalier Bichat-Claude-Bernard, 46, rue Henri-Huchard, 75877 Paris Cedex 18, France
    Rev Med Interne 24:324-7. 2003
    ..Diagnosis is supported by radiological investigations and liver biopsy. As no drug therapy appears clearly effective, liver transplantation must frequently be considered in these patients...
  72. ncbi Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis
    P Dieude
    Universite Paris 7, and Hôpital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:225-33. 2009
    ..The aim of this study was to determine whether the IRF5 rs2004640 single-nucleotide polymorphism is associated with SSc...
  73. ncbi Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension
    J Wipff
    Rene Descartes University, Medical Faculty, Rheumatology A Department, Cochin Hospital, AP HP, Paris, France
    Rheumatology (Oxford) 46:622-5. 2007
    ..A 6-base insertion in intron 7 (6bINS) of ENG has been reported to be associated with microvascular disturbance...
  74. ncbi Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis
    Bernard Combe
    Service d Immuno Rhumatologie, CHU Montpellier, INSERM U454, 34295 Montpellier Cedex 5, France
    J Rheumatol 30:2344-9. 2003
    ..To determine prognostic factors of disability in early rheumatoid arthritis (RA) and to investigate the radiological and functional course of the disease...
  75. ncbi Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis
    Jean-David Cohen
    Department of Immuno-Rhumatologie, CHU Montpellier, Montpellier I University and INSERM U454, Montpellier, France
    J Rheumatol 33:1936-41. 2006
    ..Using this instrument as an outcome variable, prognostic factors were selected and varied widely depending on the evaluated domain. The baseline HAQ score was the best predictive factor of 4 of the 5 domains of the AIMS2...
  76. ncbi Is the celiac disease model relevant to rheumatoid arthritis?
    Olivier Meyer
    Joint Bone Spine 71:4-6. 2004
  77. ncbi A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides
    Corneliu Henegar
    Hopital Cochin, Paris 5 René Descartes University, Assistance Publique Hopitaux de Paris, France
    Arthritis Rheum 58:1528-38. 2008
    ..To establish a set of clinical and paraclinical criteria potentially useful as a diagnostic screening tool for polyarteritis nodosa (PAN)...